Materialise NV provides additive manufacturing and medical software tools, and 3D printing services in the Americas, Europe, Africa, and the Asia-Pacific. The company operates through three segments: Materialise Software, Materialise Medical, and Materialise Manufacturing. The Materialise Software segment offers proprietary software through programs and platforms that enable and enhance the functionality of 3D printers, and printing operations. Its software interfaces between various types of 3D printers; and various software applications and capturing technologies, including computer-aided design/computer-aided manufacturing packages and 3D scanners; a MES, software providers. This segment serves 3D printing machine manufacturers; production companies and contract manufacturers in automotive, aerospace, consumer goods, and hearing aid industries; and 3D printing service bureaus through its sales force, website, and third-party distributors. The Materialise Medical segment provides medical software that allows medical-image based analysis, planning, and engineering, as well as patient-specific design and printing of surgical devices and implants. It serves medical device companies, hospitals, universities, research institutes, and industrial companies. The Materialise Manufacturing segment provides 3D printing services, design and engineering services, and rapid prototyping and additive manufacturing of production parts to customers serving the automotive, consumer goods industrial goods, semiconductor, art and architecture and aerospace markets. The company has collaboration agreements with Zimmer Biomet Holdings, Inc.; Encore Medical, L.P.; DePuy Synthes Companies of Johnson & Johnson; Limacorporate Spa; Mathys AG; Smith & Nephew Inc.; Corin Ltd; Medtronic Inc.; and Abbott Laboratories Inc. Materialise NV was incorporated in 1990 and is headquartered in Leuven, Belgium.…
Materialise: 3 Key Takeaways for Long-Term Investors
Materialise (NasdaqGS:MTLS) Stock Price Sinks After Q3 Results Miss Profit Expectations
Materialise (NASDAQ: MTLS) is listed on Nasdaq, where its shares trade in USD. It belongs to the Software - Application industry, part of the Technology sector, and reports about 2,556 employees.
The shares were at 5.950 USD on 20 November 2026, roughly unchanged over 52 weeks. Its 52-week range is 4.780 USD to 8.820 USD: the price is 32.5% below the high and 24.5% above the low.
At a market capitalisation of 339.14M USD, it trades at 22.9 times trailing earnings and 23.0 times forward earnings. The median trailing P/E of its 18 largest Software - Application peers is 33.6, a discount of 32% for MTLS.
Materialise reports return on equity of 3.0%, an operating margin of 3.4% and revenue up 2.1% year over year.
It holds more cash than debt, a net cash position of 82.47M EUR. Its Piotroski F-score is 6 out of 9, an average reading of its financial health. 3 analysts cover the stock; their mean price target of 9.788 USD is 64.5% above the current price. The next earnings report is expected on 18 February 2027.